Pharmaceuticals

  • The Janssen Family Dynasty: Secular Influence and a 3-Billion-Euro Fortune

    The Janssen family, one of Belgium's most influential dynasties, has positioned itself at the heart of the banking, industrial and pharmaceutical sectors. With assets estimated at over 3 billion euros, their legacy is marked by strategic alliances, notably with the Solvay group and UCB, and by rigorous management of their assets. From Daniel Janssen to Charles-Antoine Janssen, each generation has strengthened the family's grip on the Belgian economy. Discover how this family has combined tradition, innovation and strategy to become one of Belgium's wealthiest.

  • Dr. Paul Janssen: The Visionary Entrepreneur Behind a 300 Million Euro Fortune and a Pharmaceutical Legacy

    Dr. Paul Janssen, founder of Janssen Pharmaceutica, is one of the most influential figures in the Belgian pharmaceutical industry. With a legacy estimated at over 300 million euros, Janssen revolutionized medicine with innovative medicines, while remaining a central figure in the company after its takeover by Johnson & Johnson. In addition to his medical contributions, he left a significant cultural imprint, with a unique collection of pre-Columbian art. Discover how this visionary built a pharmaceutical empire while influencing Belgian art and economics.

  • De Raedt-Verheyden family: Colossal 1.7-billion-euro empire in biotechnology

    Gino De Raedt and Frederica Verheyden have built a financial empire estimated at over 1.7 billion euros, from a simple medical laboratory in 1978 to major players in European biotechnology. Their journey, marked by strategic acquisitions and a spectacular merger with Biogroup, illustrates an exceptional entrepreneurial vision. With record dividends and diversified investments in real estate and private equity, the De Raedt-Verheyden couple have become one of Belgium's largest fortunes, while preparing for the future with their daughter Ann. Their story embodies the perfect blend of scientific innovation and financial genius.

  • 151 Million : Patrick Solvay's Colossal Legacy - From Chemicals to Golf

    Immerse yourself in the world of Patrick Solvay, heir to a chemical and financial empire valued at 151 million euros. From major influence in the global chemical industry to ownership of a prestigious golf course, discover how this great-grandson of Alfred Solvay perpetuates and diversifies the legacy of one of Belgium's most influential families.